Share This
News category :
All > Rating(74)
All > 巴克莱(7)

候選減肥藥物令人期待 William Blair、 巴克萊 上調安進評級

2024-05-04T22:10

... 投資公司William Blair將其對安進的股票評級上調至「跑贏大盤」。此前,安進管理層對該公司旗下的候選減肥藥物MariTide發表了令人鼓舞的言論,該藥物的第二階段數據預計將於今年晚些時候公布。巴克萊也上調了對安進的股票評級,由「減持」

...
 recommend this page to friend   Details 
 
 
 Related news
  Benchmark重申京東 評級 為...  2024-05-18T00:  
同花順(300033)美股訊 5月17日Benchmark重申京東評級為買入,最新目標價為55.00美元。 京東於5月1...
  Macquarie維持微軟 評級 為...  2024-05-19T00:  
  JP Morgan維持愛芬奇 評級 ...  2024-05-19T00:  
  Citigroup維持霍頓房屋 評級...  2024-05-19T00:  
  Wedbush維持游戲驛站 評級 為...  2024-05-19T00:  
  TD Cowen維持The Tjx ...  2024-05-19T00:  
  Scotiabank下調 評級 馬塞...  2024-05-19T00:  
  Citigroup維持托爾兄弟 評級...  2024-05-19T00:  
  Macquarie調高 評級 京東評...  2024-05-19T00:  
  Lake Street對Missio...  2024-05-19T00:  
  Search   More 
 Latest News
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.